Tag: hbv (hepatitis b virus)

CAB/RPV LA Not for Everyone

“One of the most important considerations before switching HIV patients to injectable long-acting cabotegravir/rilpivirine [CAB/RPV LA; Cabenuva, ViiV Healthcare] is for the patient and the...

Protein Expression May Predict HBV DNA Suppression

Stopping nucleoside analog therapy in patients with hepatitis B viral (HBV) infections results in sustained viral suppression in only a minority of patients, but a...

Treatment Paradigm for Chronic HBV in Flux

These days deciding when to stop targeted treatment for chronic hepatitis B is a bigger challenge than knowing when to start, Norah A. Terrault, MD,...

Progress and Challenges in US Perinatal HBV Prevention Program

NEW YORK (Reuters Health) – The United States has made progress in identifying infants born to hepatitis B surface antigen (HBsAg)-positive women and getting them...

Mixed Outcomes in Tenofovir Trial for Chronic Hepatitis B

About one-third of patients with chronic hepatitis B maintained a profile consistent with inactive disease 1 year after withdrawal from treatment in the randomized HBRN trial, which...

Hepatocellular Carcinoma Shows Risk Factor Shift

Rates of hepatocellular carcinoma (HCC) continue to rise in the United States, but unevenly so given how the incidence has become highest in the Hispanic...

Vaccines Should Be Mandatory for All HCPs, Group Says

All healthcare personnel (HCP) should be required as a condition of employment to be immunized against vaccine-preventable diseases, the Society for Healthcare Epidemiology of America...

Hepatitis Screening Now for All Patients With Cancer on Therapy

All patients with cancer who are candidates for systemic anticancer therapy should be screened for hepatitis B virus (HBV) infection prior to or at the...